Welcome to Vertec

Vertec United Kingdom
PDF Print E-mail

 

Valuing our clients from around the world, Vertec Scientific is a trusted leader in the medical imaging and radiotherapy markets.  The integrity behind our sales and service inspires and unites the people of Vertec.  We embrace innovative development and science - bringing ideas, products, and services to advance our customers ambitions.  Together, our customers and Vertec touch the lives of millions of people every day, building lasting relationships in which all of us can take pride.

 

 

Key Facts:

  • Vertec’s corporate headquarters is situated in Silchester, UK, with a sales/service work force based in strategic areas of the country.
  • Vertec has a subsidiary company in South Africa, VertecSA, based in Johannesburg.
  • Vertec is ISO 9000 accredited since 1995 and are WEEE compliant (reg no. WEE/AD0070TY)  
  • Vertec became the first overseas distributor for Hologic Inc. in 1986, and are now the UK market leader in Bone Densitometry/DXA.  
  • Vertec holds the product license for a small radiation monitoring device - the Bleeper
  • Among the companies we represent are:  Hologic Inc., Scanflex, Viatronix, SwissRay, Siemens and Neurologica.
  • Vertec has become the UK's major supplier of Mini 'C'-arm systems for extremity imaging with the Fluoroscan 'Insight' system.
 

Our History

Founded in the UK in 1978, with a South African office established in September 2006, Vertec was privately owned until its purchase in December 1998 and is now a wholly owned subsidiary of Acal Plc.  Vertec Scientific has an unsurpassed reputation for quality of products and after sales service, of which has been built up over many years.

Our Values

The values that lead our decision making are evident in our reputation.   Frankly speaking, our values challenge us to put the needs and ambitions of the clients we serve first.

Company Structure

Through distinction in our product line and services offered, Vertec and its structure adhere to a strict set of collective ideals based on meeting the objectives of our customers and our suppliers as they relate to their overall business strategies.

Our People

Vertec recognizes that our people are our greatest assets. We have a shared desire to stretch beyond our limits in order to serve our customers and our suppliers, aiming to exceed both of their expectations.

Our Management

Vertec is a company of enduring stability and accomplishment.  Managing our business with the highest degree of professionalism is exemplified in the character and strength of our people.

Vertec News

Calypso at the Royal Marsden
 Pictured following the recent handover of a Calypso patient movement tracking system to the Radiotherapy Group at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research (ICR) in Sutton, Surrey, are (from left): Vertec sales specialist Nikki Mara, clinical oncologists Professor David Dearnaley and Dr Gerard McVey, physicist Dr Philip Evans, research radiographer Ms Helen McNair and physicists Dr Anthony Kavanagh and Dr Westley Ingram.This installation of Calypso is the first in UK. The system uses a transmitter centred feedback circuit to advise when the target is out of alignment with the treatment beam so that corrective action can be taken. The advantage for this is that dose delivery given to the target is optimised. According to Dr Evans: “Uniquely, the Calypso system uses implanted transponders to measure set-up accuracy during radiotherapy so there is zero radiation dose and set-up accuracy can be measured continuously and more rapidly than alternative systems." The Royal Marsden opened its doors in 1851 as the world’s first hospital dedicated to cancer treatment, research and education. It is a centre of excellence, and the only NHS Trust to achieve the highest possible ranking in the Healthcare Commission’s Annual Health Check for the fourth year in a row. The ICR is one of the world's leading cancer research organisations and is internationally renowned for the quality of its science. It has been ranked the UK’s top academic research centre, based on the results of the Higher Education Funding Council’s Research Assessment ExerciseTogether, the two organisations form the largest and most comprehensive cancer centre in Europe treating over 40,000 patients every year.  Comments Vertec’s Nikki Mara, “We are very pleased that the first Calypso in the UK is here at The Royal Marsden and The Institute of Cancer Research as it is a world centre for clinical excellence in the treatment of cancer patients.”